AzTrials
AzTrials

Cognitive FunctionNCT07250932

Exploring the Effectiveness of Somatosensory Cognitive Game Intervention on Cognitive and Physical Functions

A study testing somatosensory cognitive game in people with Cognitive Function, run by Taipei Medical University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study investigates the effects of somatosensory cognitive games interventions on older adults' cognitive and physical functions. The investigators plan to recruit up to 100 participants and randomly assign them to a control group or an experimental group. Read more about this study

Who is it for?
Ages 65 to 100 yearsHealthy volunteers can take part
Conditions the study is for
Cognitive Function
What is being tested?
somatosensory cognitive game
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
No sites listed yet
Study dates
Nov 2025to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Elderly individuals aged 65 and above.
  • Able to communicate in Chinese (Mandarin or Taiwanese).
  • Voluntarily participate in this study and sign a written consent form.

Who cannot join

  • Individuals with severe visual impairments or physical mobility disabilities that prevent them from participating in the game activities designed in this study.
  • Individuals diagnosed with severe dementia who are unable to understand or participate in the research process.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Exploring the Effectiveness of Somatosensory Cognitive Game Intervention on Cognitive and Physical Functions in Older Adults

This study investigates the effects of somatosensory cognitive games interventions on older adults' cognitive and physical functions. The investigators plan to recruit up to 100 participants and randomly assign them to a control group or an experimental group. The experimental group will participate in somatosensory cognitive games for 12 weeks, while the control group will receive routine care. Data will be collected via questionnaires to examine whether somatosensory cognitive games can delay declines in cognitive and physical functions in older adults.

Read the detailed description

This study investigates the effects of somatosensory cognitive games interventions on the cognitive and physical functions of older adults. The investigators plan to recruit 80 participants and randomly assign them to either a control group or an experimental group. The experimental group will participate in somatosensory cognitive games for 12 weeks, twice a week, about 30 minutes per session; the control group will receive usual care without any specific intervention. All participants will complete four questionnaire assessments to examine whether somatosensory cognitive games can slow decline in cognitive and physical functions.

Being tested
somatosensory cognitive game

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • somatosensory cognitive gameOther

    The experimental group will participate in somatosensory cognitive games for 12 weeks, twice a week, about 30 minutes per session.

Study groups in NCT07250932
Study groupRoleWhat they receive
Somatosensory Cognitive Game Intervention on Cognitive and PhysicalExperimentalNot described
Receives: Other: somatosensory cognitive game
Routine careNo interventionno Intervention on Cognitive and Physical

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Montreal Cognitive Assessment (MoCA)

    MoCA is one of the key cognitive function outcomes that investigators expect to improve after somatosensory cognitive games. MoCA assesses six cognitive dimensions, with a total score of 30. A score of 26 or higher is considered normal. MoCA score of ≤24 may indicate a risk of mild cognitive impairment (MCI), while a MoCA score of ≤20 may indicate a risk of dementia.

    Measured: 3 month follow-up

  2. Color Trails Test (CTT)

    CTT is one of the key cognitive function outcomes that investigators expect to improve after somatosensory cognitive games. CTT is widely used to assess executive function and processing speed. The first part (CTT-1) evaluates visual-motor skills and attention, while the second part of the CTT (CTT-2) assesses sequencing and cognitive flexibility. Scoring is based on the time required to complete the test, with cutoff times of 240 seconds for CTT-1 and 330 seconds for CTT-2. Shorter completion times indicate better executive function and processing speed.

    Measured: 3 month follow-up

Secondary outcomes (2)
  1. Short Physical Performance Battery (SPPB)

    SPPB is another secondary outcome measure that researchers expect to improve after intervention with somatosensory cognitive games. SPPB is mainly used to assess the physical function and mobility of elderly people, with a total score range of 0-12 points, where higher scores indicate better physical function.

    Measured: 3 month follow-up

  2. Timed Up and Go Test (TUG)

    TUG is another secondary outcome measure that researchers expect to improve after intervention with somatosensory cognitive games. TUG is an assessment tool for evaluating gait and mobility in elderly people. TUG < 10 seconds indicates normal mobility, TUG 11-20 seconds indicates those who can walk independently (but move more slowly), and TUG > 20 seconds indicates those who require assistive devices (such as walkers).

    Measured: 3 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2025
  2. Study startNov 2025 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07250932
Sponsor's protocol ID
N202509045
Status last verified
Sep 2025
First submitted
13 Nov 2025
Last updated
26 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing somatosensory cognitive game in people with Cognitive Function, run by Taipei Medical University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dorothy Bai, PhD (+886-2-27361661 Ext. 6332, dbai@tmu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Montreal Cognitive Assessment (MoCA) (time frame: 3 month follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in